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ABSTRACT
Scedosporium species are an emerging opportunist group of fungi that have been found to cause 
infections in both immunocompetent and non-immunocompetent individuals. The infections are 
not regularly distributed among different countries of the world either because of improper identi-
fi cation or other geographical reasons. Strange as it may, disseminated systemic infections have only 
been reported in some specifi c countries. We used a mouse model of disseminated infection to assess 
if strains from Nigeria were virulent and compared it to a few other strains from other countries. 
S. apiospermum isolated from Nigeria were clearly less virulent than those obtained elsewhere. This 
may be the reason why this group of fungi has not been associated with specifi c clinical problems in 
Nigeria in pa’rticular and Africa in general. 
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INTRODUCTION
Scedosporium species are filamentous fungi 
that belong to the class Euascomycetes, of 
the order Microascales, and family Microas-
caceae. Until recently, the genus Scedospo-
rium contained two species: Scedosporium 
apiospermum and Scedosporium prolificans. 
Other new species such as S. dehoogi and 
S. auranticum have been proposed and appar-
ently accepted.1 Scedosporium species were 
originally known to be soil-borne organisms, 
but they have emerged recently as opportu-
nistic pathogens in both immunocompetent 
and immunocompromised patients.2-3 They 
are known to be distributed worldwide.4-5 
Nevertheless, information on the species 
does not seem balanced, as there are very few 
reports, from Africa. Moreover, it is possible 
that the virulence of strains could vary from 
one geographical location to another. Owing 
to the apparent threat posed by this species, 
particularly because of its poor response to 
conventional antifungals,6-7 we conducted 
this study to compare the virulence of some 
species isolated from Nigeria and those from 
other geographical areas. Recently, Capilla 
and Guarro8 proposed a model of dissemi-
nated infection of this group of fungi using 
neutropenic guinea pigs and observed some 
strain-dependent differences. They also 
achieved total mortality with mean survival 
times of about 3-4 days with highest inocula 
sizes of 2x106 and 7x105. When they used the 
lowest inoculum of 3x105, mortality was re-
duced to 50% for one strain and 100% for 
the other, and the mean survival times were 
12.5 and 5.25 days, respectively. Brain and 
kidneys were extensively infected by both 
strains of Scedosporium used in that study. 
The authors therefore concluded that the 
mortality rate correlated with inoculum den-
sity, strain differences, and immune status. 
Thus, the variability in virulence observed 
among different strains of Scedosporium and 
recent reports of imported infections across 
so many countries indicate that more data 
on the virulence of a wide range of strains, 
especially from developing countries of Af-
rica are clearly needed. 
 
MATERIAL AND METHODS
Virulence studies
Isolates and preparation of inocula: Scedospo-
rium isolates tested in this study were selected 
based on a DNA-DNA reassociation experi-
ment, which separated Scedosporium apiosper-
mum isolates into three groups identifi ed as 
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groups I to III. All the isolates were fi rst cultured on potato 
dextrose agar (PDA) for 7-10 days at 30° C. The inocula were 
prepared by ﬂ ooding the surface of the agar plate with sterile 
saline, scraping the sporulating mycelium with a culture loop, 
and drawing up the resultant suspension with a sterile Pas-
teur pipette. The suspensions were then fi ltered once through 
sterile gauze to remove hyphae. The number of conidia in the 
suspension was counted with a haemocytometer, adjusted to 
(8 x 105) – (1 x 106) conidia/mL and verifi ed by plating dilu-
tions of the suspension on PDA plates. 
Animals: Male mice with a mean weight of 32 g were used. 
These animals were housed eight per cage in standard boxes 
with corncob bedding and free access to food and water. 
Infection, histopathology and statistical analysis: Inocu-
lum suspensions (0.2 mL of 106 conidia/mL) of each fungal 
strain were injected intravenously via the lateral tail vein in 
groups of eight mice. Mortality was recorded daily for 30 
days. Mean survival time (MST) was estimated by the Ka-
plan-Meier method in the SPSS software (version 10) and 
compared among groups by the log-rank test. Representa-
tive samples of organs from these animals were fi xed in 10% 
neutral buffered formaldehyde for 10 days, embedded in 
paraffi n wax and automatically processed. Sections (3 µm in 
thickness) of the embedded tissues were stained with meth-
enamine silver (Grocott) for light microscopy observations.
Comparative infectivity of isolates by different 
routes
The inocula were prepared as described above. However, 2 
x 106 conidia per mL concentration of cells were used and 
white male mice weighing 18-22 g were used. Two groups of 
6 mice each were used per route of inoculation. They were 
injected with saline suspension of the isolates tested. The in-
traperitoneal and subcutaneous dose of inoculum was 0.5 
mL, while 0.2 mL was used for the intravenous injections via 
the lateral tail vein. Half the mice population was sacrifi ced 
after two weeks and the rest after 5 weeks. The lungs, liver, 
spleen, kidneys, diaphragm, intestine, brain, and stomach 
were examined for the presence of lesions. Bits of these or-
gans and tissue were macerated and cultured on brain heart 
infusion agar (BHIA) slants supplemented with chloram-
phenicol (0.05 mg/mL) and incubated at 30° C for up to 4 
weeks. Portions of the organs and tissues showing macro-
scopic lesions were digested in 10 % KOH and observed mi-
croscopically for the presence of fungal elements. 
 
RESULTS
The result confirmed the virulence of Scedosporium spe-
cies in mice. However, all the three S. apiopsermum group 
I isolates (SA1, SA80 and SA31) could not cause death in 
mice 30 days after inoculation, as 63%, 64% and 69% of 
the mice survived, respectively, after intravenous inocu-
lation of the mice with each isolate through the lateral 
vein with 0.2 mL of 106 conidia/mL of each isolate (Fig-
ure 1). Similarly, out of the three isolates of S. apiosper-
mum tested in group II, SA35 and SA68 produced similar 
virulence patterns, as 60% of mice inoculated with each 
isolate survived after 30 days postinfection. The third 
isolate in the group, SA157, was slightly less virulent, as 
62% of the mice inoculated with prepared conidia sur-
vived after 30 days postinfection (Figure 2). In group 
III, two isolates (SA151 and SA166) showed a similar 
pattern of virulence with those in groups II and III by 
recording 59 and 63% survival after 30 days postinfec-
tion, respectively. The third isolate tested in group III, 
SA138, had a much lower virulence, as 90% of the mice 
survived 30 days postinfection (Figure 3). This isolate 
showed a significant deviation in virulence when com-
pared to the other isolates in group III or the isolates 
tested in groups I and II. Five isolates of S. prolificans 
(SP1, SP11, SP13, SP14, and SP15) were tested in addi-
tion to typed Spanish control strain, FMR3569 (Figures 
4, 5). S. prolificans isolates were generally more virulent 
than S. apiospermum. For instance, 30 days postinfec-
tion of SP1, SP13, and SP15 isolates, 10%, 35%, and 30% 
of the mice, respectively, survived. For SP11 and SP14 
isolates, 25% and 9% of mice, respectively, survived 30 
days postinfection. The S. prolificans Spanish control 
strain was significantly more virulent than any of the 
S. prolificans isolates. After nine days postinfection, all 
mice inoculated with the control strain died. The log-
rank test of statistical package for social sciences (SPSS 
version 10), used to analyze the result, placed all isolates 
tested into four classes of virulence: high, intermediate, 
low, and lower. The control strain was the only isolate 
with high virulence. Additionally, SP1 and SP14 had 
intermediate virulence, while the rest of the SP isolates 
were classified as isolates with low virulence. All SA iso-
lates had lower virulence (Table 1).
Figure 1: Survival of mice infected with SA group I isolates 
by intravenous inoculation through the lateral vein with 
(0.2 mL of 106 conidia/mL).
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Table 1. Scedosporium species grouped according to their virulence in mice
Species Degree of virulence Isolate number Mean survival time Mortality  p-value
   (MST) (days) (95% CI)
S. prolificans High FMR 3569 7.8 (5.7-8.9) 100 0.0003
  Intermediate SP14,SP1 12.94 (10.72-13.81) 90.1x -
  Low SP11,SP13,SP15 24.2 (19.51-29.72) 70 0.0009
S. apiospermum Lower SA1,SA80,SA31,SA35,SA68, 27.13 (23.90-29.20) 26# -
  SA157,SA138,SA151, SA166
  (Nigerian strains) 
*, Significance versus the group with intermediate virulence in the log-rank test; #, Mean values for the nine isolates included in 
this group - isolates were not statistically significant among them (p = 0.2510); x, Mean values for the two isolates included in 
this group - isolates were not statistically different among them (p = 0.1820).
Figure 2:  Survival of mice infected with SA group II isolates 
by intravenous inoculation through the lateral vein with 
(0.2 mL of 106 conidia/mL) conidia.
Figure 3: Survival of mice infected with SA group III isolates 
by intravenous inoculation through the lateral vein with 
(0.2 mL of 106 conidia/mL) conidia.
Figure 4:  Survival of mice infected with SP isolates: SP1, 13 
and 15 by intravenous inoculation through the lateral vein 
with (0.2 mL of 106 conidia/mL) conidia.
Figure 5: Survival of mice infected with SP isolates: SP11, 
14 and the control Spanish strain FMR 3569 by intravenous 
inoculation through the lateral vein with (0.2 mL of 
106 conidia/mL) conidia.
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Comparative infectivity of Scedosporium 
isolates
In organs and tissues, the diameter of formed lesions 
ranged from 1 to 2.5 mm. They were nodular. The for-
mation of lesions depended on the route of inoculation 
and in some cases, the time of sacrifice. In intravenously 
infected animals, lesions were seen in the liver, kidney, 
lungs, spleen, and brain (Table 2). However, no lesions 
were formed in the stomach, intestine, and diaphragm 
of these animals. This observation differed from those 
mice injected intraperitoneally, especially with regard 
to lesion formation in similar organs. The ratio of mice 
showing positive recovery results for tissue culture to 
the number of mice showing positive results for pres-
ence of lesions in the organs was similar for most of Sce-
dosporium isolates injected intravenously. 
Table 2. Distribution of lesions in mice sacrificed two weeks (2W) and 5 weeks (5W) postinfection with saline 
suspended inocula of Scedoporium apiospermum and Scedosporium prolificans isolates via intravenous route 
(A) and intraperitoneal route (B)
A               Number of mice showing positive result of recovery of culture from tissue / 
                  Number of mice showing positive result for presence of lesions in organs
Isolates Liver Kidney  Lungs Spleen Stomach Intestine Diaphragm Brain
 2W 5W 2W 5W 2W 5W 2W 5W 2W 5W 2W 5W 2W 5W 2W 5W
SA1 3/3 3/3 3/3 3/3 0/0 0/0 0/0 3/3 
 3/3 3/3 3/3 3/3 0/0 0/0 0/0 3/3
SA35 3/3 3/3 3/3 3/1 0/0 0/0 0/0 3/3
 3/3 3/3 3/3 3/3 0/0 0/0 0/0 3/3
SA68 3/3 3/2 3/3 3/3 0/0 0/0 0/0 3/3
 3/3 3/3 3/3 1/0 0/0 0/0 0/0 3/3
SP1 3/3 3/3 3/3 3/0 0/0  0/0 0/0 3/3
 3/2 3/3 3/3 3/2 0/0  0/0 0/0 2/3
SP15 3/3 3/3 3/3 2/0 0/0 0/0 0/0 3/2
 3/3 3/3 3/3 3/3 0/0 0/0 0/0 3/3
B
SA1 3/3 3/3 3/3 3/0 3/0 1/1 0/0 3/0
 3/3 3/3 3/3 3/1 3/1 3/3 0/0 3/0
SA35 3/3 3/3 3/3 3/0 3/2 2/2 1/0 2/3
 3/3 3/3 3/3 3/0 2/1 2/2 0/0 3/2
SA68 3/3 3/3 3/3 3/0 2/2 3/0 3/2 3/2
 3/3 3/2 2/3 3/1 2/0 2/2 3/1 3/3
SP1 3/2 3/3 3/0 3/3 3/2 3/3 2/0 2/0
 3/3 3/2 3/1 3/2 3/3 3/2 3/3 1/0
SP15 3/3 3/3 3/2 3/3 3/3 3/3 2/2 2/2
 3/2 3/1 3/3 3/3 3/0 3/1 3/2 2/1
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DISCUSSION
Fienberg9 and Ajello10 were the fi rst authors that document-
ed studies involving the virulence of Scedosporium species in 
animal models. They independently used different routes of 
inoculation to inject the animals and found that virulence 
appeared low when intraperitoneal inoculation was used. 
Each author was able to isolate the organism again several 
weeks after inoculation, but could not fi nd any sign of in-
jury to visceral organs of animals. Several years later, Reyes11 
and Schmitt et al.12 used the same procedure of Ajello,10 but 
they were unable to reproduce these results. The reason for 
this observation could not be immediately ascertained until 
years later when Bell13 indicated that human isolates of S. ap-
iospermum are considerably more virulent than soil or ma-
nure strains. Thus, it was then concluded that the inability to 
reproduce the results of Ajello could be probably explained 
by the use of strains with different degrees of virulence, as 
virulence of Scedosporium species is strain dependent. This 
was the main motivation for our study.
Figures 1 to 4 compare the virulence of strains isolated 
from different clinical and non-clinical sources in a mu-
rine model. All S. apiospermum strains tested in the study 
were clearly less virulent (Mean survival time (MST) of 
27.13 days and mean mortality rate of 26%) than those of 
any of the other three virulence groups of S. prolifi cans 
(MST 7.80, 12.94, and 24.20 days and mean mortality rates 
of 100.0%, 90.1%, and 70.0% for the high, intermediate, 
and low virulence groups, respectively (Table 1). Similar 
results on the high virulence of S. prolifi cans compared to 
S. apiospermum were also observed by other authors in a 
similar murine model.14,15 Although selected isolates were 
used in addition to only one reference typed Spanish strain 
due to the complexity and cost of testing so many animals, 
the result suggests that the Spanish control strain was more 
virulent than any of the Scedosporium apiospermum species 
isolated from Nigeria. It is possible that when more iso-
lates are tested, this observation may not stand. Ortoneda 
et al.14 compared Spanish isolates to isolates recovered from 
the USA and concluded that they were not more virulent 
than those from the USA. However, they could not explain 
the reason why disseminated infections by these fungi are 
more frequent in Spain than in the USA. Likewise, dis-
seminated Scedosporium infection is not very common in 
Nigeria as well. It is likely that the clinical differences ob-
served could be due to other factors, such as the different 
genetic susceptibility of people from different geographi-
cal regions. This study also demonstrates that there are no 
differences in virulence between clinical and non-clinical 
strains and that any isolate from non-clinical or clinical 
source can cause severe infections in a patient with predis-
posing factors. This seems to be in agreement with obser-
vations by Ortoneda et al.15 It is also clear from the results 
that strains with different virulent patterns can exist in the 
same region. This is supported by a similar observation by 
Bell13 who found differences in virulence between a strain 
from a patient with subcutaneous infection and a strain 
from the environment. The distribution of lesions in mice 
sacrifi ced two weeks (2W) and 5 weeks (5W) postinfec-
tion (Table 2) with saline suspended inocula of some se-
lected isolates of S. apiospermum and S. prolifi cans via the 
intravenous route (A) and intraperitoneal route (B) shows 
that the formation and persistence of lesions in organs 
and tissues depended on the route of inoculation and time 
of sacrifi ce. Lesions were seen in the liver, spleen, kidney, 
stomach, intestine, diaphragm, brain, and lungs of the in-
traperitoneallly infected mice, while no lesions were seen 
in the stomach, intestine, and diaphragm of intravenously 
inoculated animals. An interesting observation is the abil-
ity of all Scedosporium strains studied to produce lesions 
in the brain. This confi rms the predilection of these fungi 
for brain tissues, which is more often reported in patients 
of near-drowning. The ability of Scedosporium species to 
cause invasive infection is also justifi ed by its ability to at-
tack all the visceral organs, particularly when it initiates 
infection through intravenous route. It then follows that, 
the ability of any particular isolate of Scedosporium to ini-
tiate infection is not determined by geographical origin 
or source, so all isolates appear to have the capability to 
start any kind of infection when the predisposing factors 
are in place, as previously noted. Generally, we are not 
able to make so many comparisons because studies deal-
ing with the virulence of Scedosporium species are not as 
extensive as those of other fungal species. Moreover, some 
of the studies did not use the same or identical protocol. 
For instance, Lamaris and et al.16 used Drosophila melano-
gaster, contrary to our study which used mice instead. Even 
with that, they found that wild-type ﬂ ies were resistant to 
infection with both S. apiospermum and S. prolifi cans. Re-
cently, Gilgado et al.17 published their fi ndings on virulence 
of Scedosporium species based on a new reclassifi cation of 
the species and reported that S. auranticum and S. dehoogii 
were the most virulent of all species they screened. They 
also noted that S. dehoogii is only represented currently 
by fi ve environmental strains and it is unclear whether 
it is able to infect humans. However, we did not include 
these reclassifi ed species in our study and therefore could 
not compare their virulence with those of the other two 
species investigated. There appears to be a lot of reorga-
nization going on in the nomenclature of Scedopsorium 
species. Some authors recently used a molecular identifi ca-
tion technique to reidentify isolates in their collection and 
found a lot of remarkable differences.17 In general, our re-
sults correlate with clinical data because infections caused 
by S. prolifi cans are usually nonresponsive to antifungals 
and their outcomes are usually fatal compared to the sister 
species, S. apiospermum.18-19
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